Press Release

EcoFlow Powers Up for Amazon's Prime Big Deals Day with Unbeatable Savings

Fall into savings with exclusive deals on best-selling products Oct. 1 to 15 SEATTLE, Oct. 1, 2023 /PRNewswire/ — With the return of cold weather, EcoFlow, a portable power and eco-friendly energy solutions company, is offering its biggest discounts ever on its best-selling portable power stations for Amazon’s Prime Big Deals Day sales event. Customers can […]

Read More
Press Release

One half-day of training using a few hundred dollars yields similar results to mainstream large models, open-source and commercial-free domain-specific LLM solution

SINGAPORE, Oct. 1, 2023 /PRNewswire/ — Recently, Colossal-AI built a remarkable domain-specific large language model (LLM) by utilizing only a few hundred dollars training costs. It can be readily applied across various domains, facilitating the economical construction of large AI models. The solution is accessible without any commercial restrictions, with complete transparency extended to the entire […]

Read More
Press Release

ESY SUNHOME Unveils Cutting-Edge Energy Solutions at Melbourne's ALL-Energy Exhibition

SHENZHEN, China, Oct. 2, 2023 /PRNewswire/ — ESY SUNHOME, a dynamic entrant in the renewable energy sector, is poised to introduce its latest pioneering products at the ALL-Energy Exhibition in Melbourne, scheduled for October 25-26, 2023. Simultaneously, the company will officially announce the imminent release of its  three-phase product line by year-end. Come and Join us! […]

Read More
Press Release

SS&C Completes Acquisition of Iress' Managed Funds Administration Business

WINDSOR, Conn., Oct. 2, 2023 /PRNewswire/ — SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced it has completed its acquisition of the managed funds administration (MFA) business from Iress Limited. Around 150 team members have joined SS&C Global Investor & Distribution Solutions, reporting to Euan McLeod, Head of Transfer Agency, APAC.  "We are pleased to welcome the MFA team’s employees, […]

Read More
Press Release

Singapore's Leading Upstream Energy Manufacturer OMS and A*STAR Sign MoU to Spearhead R&D For the Regional Oil and Gas Sector

Witnessed by Mr. Alvin Tan, Minister of State, Ministry of Trade and Industry, the MoU signing took place at Singapore Expo Max Atria during the 12th Global Additive Manufacturing Summit 2023 on 29 September. The collaboration looks to bolster R&D and innovation efforts across Singapore’s additive manufacturing sector, support workforce training and upskilling, application development […]

Read More
Press Release

Leading Independent Proxy Advisory Firm Glass Lewis Recommends IMAX China Shareholders Vote "FOR" the Privatization Transaction with IMAX Corporation

Glass Lewis and ISS Now Both Recommend Support For the Privatization Transaction with IMAX NEW YORK, Oct. 2, 2023 /PRNewswire/ — IMAX Corporation (NYSE: IMAX) today announced that leading proxy advisory firm Glass, Lewis & Co. ("Glass Lewis") has recommended that shareholders of IMAX China (HKSE:1970), a Hong Kong-listed subsidiary established by IMAX Corporation to […]

Read More
Press Release

NEON Group Forms Joint Venture with Itochu Property Development and Sankei Building for Strategic Expansion in Japan

SINGAPORE, Oct. 2, 2023 /PRNewswire/ — NEON Group Limited ("NEON", the "Company"/collectively with its subsidiaries, the "Group"), a global leader in creating and producing immersive experiences, enters into a joint venture with Itochu Property Development, Ltd. and Sankei Building Co., Ltd., laying the cornerstone for the Group’s strategic expansion plans in Japan. Photo on left: […]

Read More
Press Release

WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

WUXI, China, Oct. 2, 2023 /PRNewswire/ — WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its strategic partner, Amicus Therapeutics ("Amicus") (Nasdaq: FOLD), on receiving U.S. FDA’s approval for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) 65mg capsules. This two-component therapy is indicated for those adults living with […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.